Kidney transplant breakthrough: weekly blood tests could replace daily Anti-Viral pills

NCT ID NCT06798909

Summary

This study compares two approaches to prevent CMV infection in kidney transplant patients who receive an organ from a CMV-positive donor. One group takes daily antiviral medication for 200 days, while the other group gets weekly blood tests for 100 days and only takes medication if the virus is detected. Researchers want to see which method better prevents CMV disease while minimizing side effects and medication use.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KIDNEY DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Emory University School of Medicine

    RECRUITING

    Atlanta, Georgia, 30322, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Medical College of Virginia Commonwealth

    RECRUITING

    Richmond, Virginia, 23219, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Robert Wood Johnson Health Network Barnabas Health

    RECRUITING

    Livingston, New Jersey, 07039, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of California, San Francisco School of Medicine

    RECRUITING

    San Francisco, California, 94117, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Miami Miller School of Medicine

    RECRUITING

    Miami, Florida, 33136, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.